Single-cell Omics Market Trends

Growth Drivers

Rising Instances of Cancer– Cancer is a complex disease that consists of diverse cell populations with distinct genetic and phenotypic profiles. Single-cell omics provide a powerful tool to segregate cancer cells. By analyzing individual cancer cells, researchers can identify rare cell populations that contribute to tumor development progression, and response to therapy.
Increasing Demand for Biologics– According to the Food and Drug Administration, the Center for Drug Evaluation and Research (CDER) authorized 37 innovative pharmaceuticals in 2022, either as new molecular entities (NMEs) through New Drug Applications (NDAs) or as new therapeutic biological products through Biologics License Applications (BLAs). Single-cell omics can aid in the section and optimization of cell aid in the selection and optimization of cell lines for biologics production.
Development of Innovative Products– CellenCHIP 384 for single-cell omics sample preparation was introduced as an essential component in the new cellenCHIP 384 by SCIENION and Cellenion. It expands the cellenONE's robotic capacity for miniaturization and high productivity operations. The field of single-cell omics is rapidly evolving, driven by continuous advancements in technologies and methodologies. These technological advancements attract researchers and fuel the demand for these innovative products.

Challenges

Single-Cell Omics Technique is Expensive- The need for specialized equipment, reagents, and data analysis resources adds to the overall cost. Affordability and cost-effectiveness of single-cell omics technologies are significant considerations for their widespread implementation, especially in resource-limited settings or for small research institutes.
Technical Complications Associated with the Research
Lack of Standardized Protocols and Benchmark Datasets

Single-cell Omics Market: Key Insights

Base Year	2022
Forecast Year	2023-2035
CAGR	~22%
Base Year Market Size (2022)	~ USD 3.0 Billion
Forecast Year Market Size (2035)	~ USD 30.0 Billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

Increasing incidences of cancer, rising investment in cell therapy, and technological advancement of single-cell techniques are the major factors driving the market growth.

The market size of single-cell omics is anticipated to attain a CAGR of around 22% over the forecast period, i.e., 2023 â€“ 2035.

The major players in the market are 10x Genomics, Inc., Becton, Dickinson and Company (BD), CELLENION, PerkinElmer Inc., ANGLE plc, Illumina, Inc., Bio-Rad Laboratories, Inc., Mission Bio Inc., Standard BioTools Inc. and Ultima Genomics, Inc.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by application, product, end user, and by region.

The oncology segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

There is no standardization and the higher cost of single-cell omics is estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

Single-cell Omics Market Trends